DAVISON DANIEL PAUL (Chief Financial Officer) reported 2 transactions at DIPLOMAT PHARMACY, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/10/2020ACC: 0001104659-20-013499
Officer· Chief Financial Officer
Since Apr 2019
-330.69K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
330.69K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−43.21K
Price / share
—
Trade value
—
% of position
17.8%
2/10/2020
243.21K→200K
Common Stock
Direct
Shares
−200K
Price / share
—
Trade value
—
% of position
New position
2/10/2020
200K→0.00
Total
Net shares
−243.21K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2020 | D · Disposition | −43.21K | — | — | 17.8% | 243.21K | 200K |
| Common Stock Direct | 2/10/2020 | D · Disposition | −200K | — | — | New position | 200K | 0.00 |
| Total | −243.21K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option to Acquire Common Stock
Direct
Converts to
Common Stock
87.48K shares
Shares
−87.48K
Strike price
405.90
Held after
0.00
Exercisable
—
2/10/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option to Acquire Common Stock Direct | Common Stock87.48K shares | 2/10/2020 | D · Disposition | −87.48K | 405.90 | — | 0.00 |